KeyCorp Increases Encompass Health (NYSE:EHC) Price Target to $135.00

Encompass Health (NYSE:EHC - Free Report) had its price objective raised by KeyCorp from $122.00 to $135.00 in a research note released on Tuesday,Benzinga reports. KeyCorp currently has an overweight rating on the stock.

Several other research analysts also recently commented on EHC. William Blair reaffirmed an "outperform" rating on shares of Encompass Health in a report on Friday, February 7th. Truist Financial restated a "buy" rating and set a $135.00 target price (up previously from $116.00) on shares of Encompass Health in a research report on Monday, April 28th. Barclays lifted their price target on Encompass Health from $118.00 to $129.00 and gave the company an "overweight" rating in a research report on Friday, April 25th. UBS Group increased their price objective on Encompass Health from $117.00 to $130.00 and gave the stock a "buy" rating in a report on Monday, April 28th. Finally, Wall Street Zen raised Encompass Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, May 24th. Eight equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $122.71.

Encompass Health Stock Performance

Shares of Encompass Health stock traded up $1.00 during trading hours on Tuesday, hitting $121.01. 977,100 shares of the company's stock traded hands, compared to its average volume of 701,552. The stock has a market capitalization of $12.20 billion, a price-to-earnings ratio of 27.13, a PEG ratio of 2.31 and a beta of 0.91. Encompass Health has a 12-month low of $82.74 and a 12-month high of $122.09. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04. The company has a fifty day simple moving average of $109.93 and a 200-day simple moving average of $102.01.

Encompass Health (NYSE:EHC - Get Free Report) last announced its quarterly earnings data on Thursday, April 24th. The company reported $1.37 earnings per share for the quarter, beating the consensus estimate of $1.19 by $0.18. Encompass Health had a return on equity of 17.56% and a net margin of 8.48%. The business had revenue of $1.46 billion during the quarter, compared to analyst estimates of $1.43 billion. During the same period in the prior year, the company earned $1.12 earnings per share. Encompass Health's revenue was up 10.6% compared to the same quarter last year. Equities research analysts anticipate that Encompass Health will post 4.8 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be given a $0.17 dividend. The ex-dividend date of this dividend is Tuesday, July 1st. This represents a $0.68 annualized dividend and a yield of 0.56%. Encompass Health's payout ratio is presently 14.05%.

Insider Activity at Encompass Health

In other Encompass Health news, CEO Mark J. Tarr sold 118,384 shares of the firm's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $121.53, for a total transaction of $14,387,207.52. Following the sale, the chief executive officer now directly owns 527,070 shares of the company's stock, valued at $64,054,817.10. This trade represents a 18.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP John Patrick Darby sold 10,000 shares of the stock in a transaction dated Tuesday, April 29th. The stock was sold at an average price of $114.79, for a total value of $1,147,900.00. Following the sale, the executive vice president now owns 79,710 shares of the company's stock, valued at $9,149,910.90. This represents a 11.15% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 132,663 shares of company stock worth $16,034,082. Corporate insiders own 2.00% of the company's stock.

Institutional Trading of Encompass Health

A number of institutional investors and hedge funds have recently bought and sold shares of EHC. Pinnacle Wealth Planning Services Inc. grew its position in shares of Encompass Health by 4.0% during the first quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company's stock valued at $263,000 after purchasing an additional 99 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its holdings in Encompass Health by 19.0% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company's stock valued at $73,000 after buying an additional 115 shares in the last quarter. US Bancorp DE increased its stake in Encompass Health by 9.6% in the 4th quarter. US Bancorp DE now owns 1,380 shares of the company's stock worth $127,000 after acquiring an additional 121 shares during the last quarter. Signaturefd LLC raised its holdings in shares of Encompass Health by 21.6% during the 4th quarter. Signaturefd LLC now owns 704 shares of the company's stock worth $65,000 after acquiring an additional 125 shares in the last quarter. Finally, Arlington Trust Co LLC boosted its position in shares of Encompass Health by 22.9% during the 1st quarter. Arlington Trust Co LLC now owns 671 shares of the company's stock valued at $68,000 after acquiring an additional 125 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.